We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 08, 2021

Impact of Short- and Long-Acting GLP-1 Receptor Agonists on Digestive and Pancreatic Function and Gastrointestinal Side Effects

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Macronutrient Intake, Appetite, Food Preferences and Exocrine Pancreas Function After Treatment With Short- and Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes
Diabetes Obes Metab 2021 Jun 29;[EPub Ahead of Print], DR Quast, MA Nauck, N Schenker, BA Menge, C Kapitza, JJ Meier

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading